Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Embera and Exponential sign clinical development agreement for EMB-001C

Feb. 17, 2010

Pregabalin shows potential as a treatment for alcohol withdrawal syndrome

Feb. 8, 2010

Swissmedic approves BTG's DigiFab for life-threatening digitalis intoxication

Feb. 5, 2010

Oxytocin attenuates methamphetamine self-administration in rats

Feb. 4, 2010

Beta-lactam antibiotic ceftriaxone reduces cocaine-seeking behavior in rats

Jan. 28, 2010

Preliminary trial supports use of dextroamphetamine for methamphetamine addiction

Jan. 28, 2010

Cleveland BioLabs initiates dosing in phase Ib trial of CBLB-502

Jan. 21, 2010

Aeolus invited to submit full proposal to BARDA for further development AEOL-10150

Jan. 18, 2010

Kappa-opioid receptor antagonists claimed by Janssen for treatment of addiction

Dec. 29, 2009

Cleveland BioLabs initiates enrollment in safety study of CBLB-502 for ARS

Nov. 27, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...